Cargando…
Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
BACKGROUND: Achieving and maintaining a low-risk profile is associated with favorable outcome in pulmonary arterial hypertension (PAH). The effects of treatment on risk profile are variable among patients. OBJECTIVE: To Identify variables that might predict the response to treatment with phosphodies...
Autores principales: | Garcia, Agustin R., Blanco, Isabel, Ramon, Lluis, Pérez-Sagredo, Jesús, Guerra-Ramos, Francisco J., Martín-Ontiyuelo, Clara, Tura-Ceide, Olga, Pastor-Pérez, Francisco, Escribano-Subías, Pilar, Barberà, Joan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503122/ https://www.ncbi.nlm.nih.gov/pubmed/37715261 http://dx.doi.org/10.1186/s12931-023-02531-1 |
Ejemplares similares
-
Circulating Cell Biomarkers in Pulmonary Arterial Hypertension: Relationship with Clinical Heterogeneity and Therapeutic Response
por: Tura-Ceide, Olga, et al.
Publicado: (2021) -
Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
por: Rodríguez-Chiaradía, Diego A., et al.
Publicado: (2023) -
Updated Perspectives on Pulmonary Hypertension in COPD
por: Blanco, Isabel, et al.
Publicado: (2020) -
Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension
por: Callejo, Maria, et al.
Publicado: (2020) -
Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023)